Market Potential

MAT Rank 1 2 3 4 5 8 Rank 1 2 3 4 5 BRANDS R03DS ACEBROPHYLLINE AB PHYLLINE AB-FLO BROPHYLE ACEBROFACT RESPIRA ACE ASCOVENT Sol R03EC ACEBROPHYLLINE AB PHYLLINE ASCOVENT Liq ACELAST MACPHYLLIN EROPHYLLINE COMPANY SUN* LUPIN LIMITED EMCURE* ZYDUS CADILA* GENO Majesta Div Value 27 9.8 4.2 2.0 1.5 1.3 0.9 1.9 0.8 0.6 0.2 0.2 0.1 Aug Mat 11 Val MS% Val grth 100.00 47 36.81 52 15.84 11 7.52 48 5.57 -18 4.87 76 3.35 -20 100.00 44.71 30.95 10.00 8.61 5.73 52 51 -9 3979 356 1808 Unit 2293 687 287 211 131 154 84 97 42 20 19 11 5

SUN* Majesta Div RANBAXY* MACLEODS PHARMA MICRO LABS*

Very upcoming market and dominatesd by solid market Every HQ has potential to maximum 700 units of Ascovent

Key Marketing Issues

Promotion Priority P6/P7 Least noise level due to other priority brand clutter Weak franchise at key prescribers

Critical success factors Prioritize brand promotion focus Develop Key specialties

Enhance P/D from existing prescribers Increase exposure & focus on conversion

Marketing strategies
Prioritize brand promotion focus P4 / P5 Communication : emphasis on multimodal action

Enhance prescriber base and prescription support

Enhance P/D from existing prescribers

Communication Strategy
CP / CHEST / GP

Marketing strategies
Promote to all potential prescribers after thorough RCPA campaign

Modus Operandi : Check chemist availability of Ascovent Ensure availability immediately by POB Be assured delivery on phone to chemist and stockiest Detail as a first brand Leave sample / brand reminder Take commitment from Doctor for inaugural prescription

Call to chemist to check Rx of Ascovent

If doctor prescribes, then next day or next week or in next visit offer doctor THANK YOU card.

Q3 Promotogram
LAKSHA DAILY 1 CP / CHEST CAMPAIGN Monthly Sampling Thank You card

LBL on multimodal actions